Abstract
Scleromyxoedema is a variant of lichen myxoedematosus (papular mucinosis), one of the primary cutaneous mucinoses. The disease is rare and the aetiology is unknown. The characteristic features are (1) infiltrative skin lesions due to deposition of acid mucopolysaccharide in the dermis; (2) normal thyroid function; and (3) a serum paraprotein which is found in most, but not all, cases1. The clinical and histological appearances, paraproteinaemia, complications, and management will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hill, T.G., Crawford, J.N., and Rogers, C.C. (1976). Successful management of lichen myxedematosus. Arch. Dermatol, 112, 67–9
Dubreuilh, W. (1906). Fibromes miliares folliculaires: sclérodermic consécutive. Ann. Dermatol. Syph., 7, 569–73
Montgomery, H. and Underwood, L.J. (1953). Lichen myxedematosus (differentiation from cutaneous myxedemas or mucoid states). J. Invest. Dermatol., 20, 213–33
Gottron, H.A. (1954). Skleromyxödem (Eine eigenartige Erscheinungsform von Myxothesaurodermie.) Arch. Dermatol. Syph., 199, 71–91
Wright, R.C., Franco, R.S., Denton, M.D. and Blaney, D.J. (1976). Scleromyxedema. Arch. Dermatol., 112, 63–6
Jepsen, L.V. (1980). Two cases of scleromyxoedema. Acta Dermatol. Venereol. (Stockholm), 60, 77–9
McCuistion, C.H. and Schoch, Jr, E.P. (1956). Autopsy findings in lichen myxedematosus. Arch. Dermatol., 74, 259–62
Rudner, E.J., Mehregan, A. and Pinkus, H. (1966). Scleromyxedema. A variant of lichen myxedematosus. Arch. Dermatol., 93, 3–12
Shapiro, C.M., Fretzin, D. and Norris, S. (1970). Papular mucinosis. J. Am. Med. Assoc, 214, 2052–4
Johnson, B.L., Horowitz, I.R., Charles, C.R. and Cooper, D.L. (1973). Dermatomyositis and lichen myxedematosus: a clinical, histopathological and electron microscopic study. Dermatologica, 147, 109–22
Harper, R.A. and Rispler, J. (1978). Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science, 199, 545–7
Alligood, T.R., Burnett, J.W. and Raines, B.L. (1981). Scleromyxoedema associated with esophageal aperistalsis and dermal eosinophilia. Cutis, 28, 60–4
Muldrow, M.L. and Bailin, P.L. (1983). Scleromyxedema associated with IgG lambda multiple myeloma. Cleve. Clin Q., 50, 189–95
Perry, H.O., Montgomery, H. and Stickney, J.M. (1960). Further observations on lichen myxedematosus. Ann. Intern. Med., 53, 955–69
Findlay, G.H. and Simson, I.W. (1960). Scleromyxoedema. S. Afr. Med. J., 34, 69–71
James, K., Fudenberg, H., Epstein, W.L. and Shuster, J. (1967). Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus). Clin. Exp. Immunol., 2, 153–66
Macfarlane, A.W., Davenport, A., Verbov, J.L. and Goldsmith, H.J. (1987). Scleromyxoedema. Successful treatment with plasma exchange amd immunosuppression. Br. J. Dermatol., 117, 653–7
McCarthy, J.T., Osserman, E., Lombardo, P.C. and Takatsuki, K. (1964). An abnormal serum globulin in lichen myxedematosus. Arch. Dermatol., 89, 446–50
Verbov, J.L. (1969). Scleromyxoedema — a variant of lichen myxoedematosus (papular mucinosis). Br. J. Dermatol., 81, 871–3
Donald, G.F., Hensley, W.J. and McGovern, V.J. (1953). Lichen myxoedematosus (papular mucinosis): a brief review of the literature and report of a case which failed to respond to ACTH and cortisone. Australas. J. Dermatol., 2, 28–34
Fowlkes, R.W., Blaylock, W.K. and Mullinax, F. (1967). Immunologic studies in lichen myxedematosus. Arch. Dermatol., 95, 370–4
Howsden, S.M., Herndon, Jr, J.H. and Freeman, R.G. (1975). Lichen myxedematosus. A dermal infiltrative disorder responsive to cyclophosphamide therapy. Arch. Dermatol., 111, 1325–30
Danby, F.W., Danby, C.W.E. and Pruzanski, W. (1976). Papular mucinosis with IgG (kappa) M component. Can. Med. Assoc. J., 114, 920–2
Lai A Fat, R.F.M., Suurmond, D., Rádl, J. and van Furth, R. (1973). Scleromyxoedema (lichen myxoedematosus) associated with a paraprotein, IgG1 of type kappa. Br. J. Dermatol., 88, 107–16
Farmer, E.R., Hambrick, Jr, G.W. and Shulman, L.E. (1982). Papular mucinosis. A clinicopathologic study of four patients. Arch. Dermatol., 118, 9–13
Jessen, R.T., Straight, M. and Becker, L.E. (1978). Lichen myxedematosus. Treatment with cyclophosphamide. Int. J. Dermatol., 17, 833–9
Lowe, N.J., Dufton, P.A., Hunter, R.D. and Vickers, C.F.H. (1982). Electron-beam treatment of scleromyxoedema. Br. J. Dermatol., 106, 449–54
Brenner, S. and Yust, I. (1984). Treatment of scleromyxedema with etretinate. J. Am. Acad. Dermatol., 10, 295–6
Westheim, A.I. and Lookingbill, D.P. (1987). Plasmapheresis in a patient with scleromyxedema. Arch Dermatol., 123, 786–9
Rowell, N.R., Waite, A. and Scott, D.G. (1969). Multiple serum protein abnormalities in lichen myxoedematosus. Br. J. Dermatol., 81, 753–8
Feldman, P., Shapiro, L., Pick, A.I. and Slatkin, M.H. (1969). Scleromyxedema. A dramatic response to melphalan. Arch. Dermatol., 99, 51–6
Lawrence, D.A., Tye, M.J. and Liss, M. (1972). Immunochemical analysis of the basic immunoglobulin in papular mucinosis. Immunochemistry, 9, 41–9
Penmetcha, M., Highet, A.S. and Hopkinson, J.M. (1987). Failure of PUVA in lichen myxoedematosus: acceleration of associated multiple keratoacanthomas with development of squamous carcinoma. Clin. Exp. Dermatol., 12, 220–3
Harris, R.B., Perry, H.O., Kyle, R.A. and Winkelmann, R.K. (1979). Treatment of scleromyxedema with melphalan. Arch. Dermatol., 115, 295–9
Huth, K., Ehlers, G., Knoth, W., et al. (1972). Lichen myxoedematosus bei Makroglobulinämie Waldenström mit Polyneuropathie und Carpaltunnel-syn-drom. Dtsch. Med. Wochenschr., 97, 152–9
Coskey, R.J. and Mehregan, A. (1977). Papular mucinosis. Int. J. Dermatol., 16, 741–4
Hardie, R.A., Hunter, J.A.A., Urbaniak, S. and Habeshaw, J.A. (1979). Spontaneous resolution of lichen myxoedematosus. Br. J. Dermatol., 100, 727–30
Cheung, H.S., Nicoloff, J.T., Kamiel, M.B., Spolter, L. and Nimni, M.E. (1978). Stimulation of fibroblastic biosynthetic activity by serum of patients with pretibial myxedema. J. Invest. Dermatol., 71, 12–17
Ohta, A., Uitto, J., Oikarinen, A.I., et al. (1987). Paraproteinaemia in patients with scleredema. J. Am. Acad. Dermatol., 16, 96–107
Truhan, A.P. and Roenigk, H.H. (1986). The cutaneous mucinoses. J. Am. Acad. Dermatol., 14, 1–18
Proppe, A., Becker, V. and Hardmeier, T. (1969). Skleromyxödem Arndt-Gottron und Plasmacytom. Hautarzt, 20, 53–9
Dalton, J.E., Booth, B.H., Gray, H.R. and Evans, P.V. (1961). Lichen myxedematosus (papular mucinosis). Arch. Dermatol., 83, 230–42
de Mauberge, J., Ledoux, M., Collart, F., et al. (1987). Scléromyxoedème (Arndt-Gottron). Dermatologica, 174, 197–8
Piper, W., Hardmeier, T. and Schäfer, E. (1967). Das Skleromyxödem Arndt-Gottron: eine paraproteinämische Erkrankung. Schweiz. Med. Wochenschr., 97, 829–38
Farr, P.M. and Ive, F.A. (1984). PUVA treatment of scleromyxoedema. Br. J. Dermatol., 110, 347–50
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Macfarlane, A.W., Verbov, J.L. (1988). The Diagnosis and Management of Scleromyxoedema. In: Verbov, J.L. (eds) Tumours, Lymphomas and Selected Paraproteinaemias. New Clinical Applications, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2623-3_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-2623-3_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7683-8
Online ISBN: 978-94-009-2623-3
eBook Packages: Springer Book Archive